ES2147200T3 - Uso de un veneno de himenopteros para la fabricacion de un medicamento para tratar infecciones por virus de adn. - Google Patents

Uso de un veneno de himenopteros para la fabricacion de un medicamento para tratar infecciones por virus de adn.

Info

Publication number
ES2147200T3
ES2147200T3 ES93912693T ES93912693T ES2147200T3 ES 2147200 T3 ES2147200 T3 ES 2147200T3 ES 93912693 T ES93912693 T ES 93912693T ES 93912693 T ES93912693 T ES 93912693T ES 2147200 T3 ES2147200 T3 ES 2147200T3
Authority
ES
Spain
Prior art keywords
virus infections
dna virus
manufacture
hymenopters
poison
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93912693T
Other languages
English (en)
Inventor
Michael Hansen
Ole Gyring Nieben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2147200T3 publication Critical patent/ES2147200T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds
    • Y10S530/858Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Insects & Arthropods (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL USO DE VENENO DE HIMENOPTEROS O DE LOS COMPONENTES PROTEINICOS O POLIPEPTIDOS QUE SE ENCUENTRAN EN EL MISMO PARA LA PRODUCCION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE INFECCIONES PROVOCADAS POR VIRUS DEL ADN Y A UN METODO PARA EL TRATAMIENTO DE MAMIFEROS CON INFECCIONES PROVOCADAS POR EL VIRUS DE ADN EN LOS QUE SE UTILIZA EL VENENO DE HIMENOPTEROS O LOS COMPONENTES PROTEINICOS O POLIPEPTIDOS QUE SE ENCUENTRAN EN EL MISMO.
ES93912693T 1992-06-24 1993-06-24 Uso de un veneno de himenopteros para la fabricacion de un medicamento para tratar infecciones por virus de adn. Expired - Lifetime ES2147200T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK92828A DK82892D0 (da) 1992-06-24 1992-06-24 Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner

Publications (1)

Publication Number Publication Date
ES2147200T3 true ES2147200T3 (es) 2000-09-01

Family

ID=8098009

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93912693T Expired - Lifetime ES2147200T3 (es) 1992-06-24 1993-06-24 Uso de un veneno de himenopteros para la fabricacion de un medicamento para tratar infecciones por virus de adn.

Country Status (13)

Country Link
US (2) US5827829A (es)
EP (1) EP0653939B1 (es)
JP (1) JP3631245B2 (es)
AT (1) ATE190492T1 (es)
AU (1) AU4312093A (es)
CA (1) CA2138793C (es)
DE (1) DE69328102T2 (es)
DK (2) DK82892D0 (es)
ES (1) ES2147200T3 (es)
GR (1) GR3033698T3 (es)
NO (1) NO310058B1 (es)
PT (1) PT653939E (es)
WO (1) WO1994000137A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9531698A (en) * 1997-10-15 1999-05-03 Alk A/S Composition and method for treating an encephalomyelopathic, demyelinating or autoimmune disease
US6372471B1 (en) 1998-10-01 2002-04-16 The Rockefeller University Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
US20040081702A1 (en) 2000-04-14 2004-04-29 Kim Christopher M. Bee venom treatment without the sting
JP5358574B2 (ja) * 2007-08-17 2013-12-04 アルション セラピューティクス, インコーポレイテッド 高濃度の局所麻酔薬調合物
US8119694B2 (en) 2008-08-15 2012-02-21 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
CN102988263B (zh) * 2012-12-20 2014-08-20 中国科学院南海海洋研究所 一种具有护唇、美唇功效的蜂毒组合物
KR101596344B1 (ko) * 2013-10-30 2016-02-22 주식회사 청진바이오텍 정제봉독을 이용한 동물의 바이러스성 질환의 예방 및/또는 치료용 조성물
US10232048B1 (en) 2014-11-18 2019-03-19 Divine Api-Logics, LLC Apitherapy method and composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856936A (en) * 1973-05-07 1974-12-24 Schuyler Dev Corp Composition and method for cortisol control
JPS55149214A (en) * 1979-05-10 1980-11-20 Toyama Chem Co Ltd Medical composition consisting of extract from liquid in bee poison gland
US4822608A (en) * 1987-09-14 1989-04-18 Vespa Laboratories, Inc. Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof
WO1990011766A1 (en) * 1989-04-13 1990-10-18 Vespa Laboratories, Inc. Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
KR970005329B1 (ko) * 1989-12-07 1997-04-15 게에스에프-프로슝첸트룸 퓌르 움벨트 운트 게순드하이트, 게엠베하 포유 동물의 레트로바이러스 감염 치료용 조성물

Also Published As

Publication number Publication date
EP0653939B1 (en) 2000-03-15
DE69328102T2 (de) 2000-11-09
AU4312093A (en) 1994-01-24
DK0653939T3 (da) 2000-08-28
US5958887A (en) 1999-09-28
DE69328102D1 (de) 2000-04-20
DK82892D0 (da) 1992-06-24
NO310058B1 (no) 2001-05-14
PT653939E (pt) 2000-08-31
CA2138793C (en) 2004-03-09
GR3033698T3 (en) 2000-10-31
NO945031D0 (no) 1994-12-23
JP3631245B2 (ja) 2005-03-23
EP0653939A1 (en) 1995-05-24
ATE190492T1 (de) 2000-04-15
US5827829A (en) 1998-10-27
NO945031L (no) 1994-12-23
CA2138793A1 (en) 1994-01-06
JPH07508010A (ja) 1995-09-07
WO1994000137A1 (en) 1994-01-06

Similar Documents

Publication Publication Date Title
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
ATE277612T1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DK85786A (da) Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf
ES2160707T3 (es) Composiciones que comprenden agentes deteriorantes del adn y p53.
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
RU94045825A (ru) Применение материала, полученного из mycobacterium vaccae для производства терапевтического средства для лечения психических заболеваний, способ лечения психических заболеваний, продукт, содержащий антигенный и/или иммунорегуляторный материал, фармацевтическое средство
ATE240743T1 (de) Verfahren und substanzen gegen protozoen
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
DK0722344T3 (da) Fremgangsmåde til virusinaktivering i nærvær af en polyether og et middel
BR9105783A (pt) Polipeptidio,processo para o tratamento em vidro de neuronios e composicoes celular e farmaceutica
ES2147200T3 (es) Uso de un veneno de himenopteros para la fabricacion de un medicamento para tratar infecciones por virus de adn.
AR005750A1 (es) Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
AU6111294A (en) Composition for use in the treatment of tumours and the immunization of humans and animals
ATE306275T1 (de) Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
ATE245438T1 (de) Verwendung von oligomerem matrixprotein aus knorpel zur behandlung von rheumatoider arthritis
ATE184287T1 (de) Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen
AU3577589A (en) Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
BR9205877A (pt) Processo e composiçao para o tratamento de infecçoes por herpes.
UA7955A (uk) Спосіб лікування туберкульозу легенів
DE59405845D1 (de) Verwendung von 2-Methylamino-2-phenylcyclohexanon zur Behandlung von Infektionen und zur Immunmodulation
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 653939

Country of ref document: ES